This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

20 Apr 2011

Amylin Pharmaceuticals Reports First Quarter Financial Results

Amylin has reported revenues of $152.7m for the first quarter ended 31 March 2011.

Amylin Pharmaceuticals, a biopharmaceutical company engaged in discovery, development and commercialization of medicines, has reported financial results for the quarter ended March 31, 2011.


The Company reported total revenue of $152.7 million for the quarter ended March 31, 2011, which includes net product sales of $150.8 million and revenues under collaborative agreements of $1.9 million. Non-GAAP operating loss was $3.2 million for the quarter ended March 31, 2011<

Related News